Primer Capital: A venture capital firm investing in diverse pharmaceutical and biotech sectors in Russia.
Location
Moscow, RU
Founded
2015
Primer Capital is a venture capital firm focused on investing in pharmaceutical and biotechnology industries. Their portfolio spans diverse sectors including oncology, rheumatology, and surgery, with a primary focus on the Russian market. While specific investment sizes are not disclosed, they participate in seed and early-stage funding rounds.
The firm's portfolio includes MatriSys Bioscience, a company that has raised $3 million in funding. Primer Capital's investment strategy emphasizes supporting innovative projects in the life sciences sector, aiming to contribute to advancements in medical treatments and technologies. Their expertise in the Russian biotech landscape positions them as a valuable partner for startups in this region.
Primer Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Follow-on Investments1
Current Portfolio Count2
Top Investment Stages
Seed3 (100.0%)
Stage Mix
Seed 100%
Concentration shown as share of disclosed investments by stage.